Holger H.H. Erb

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

Martin Puhr, Julia Hoefer, Georg Schäfer et al. · American Journal Of Pathology · 2012 · 261 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines

Frédéric R. Santer, Philipp P.S. Höschele, Su Jung Oh et al. · Molecular Cancer Therapeutics · 2011 · 247 citations

Life Sciences, Oncology, Pharmacology +17

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling

Giovanna Nappo, Florian Handle, Frédéric R. Santer et al. · Oncogenesis · 2017 · 95 citations · Full text

Life Sciences, Cell Biology, Oncology +17

PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21

Julia Hoefer, Georg Schäfer, Helmut Klocker et al. · American Journal Of Pathology · 2012 · 83 citations · Full text

Medicine, Molecular Biology, Oncology +14

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Su Jung Oh, Holger H.H. Erb, Alfred Hobisch et al. · Endocrine Related Cancer · 2012 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17